Call for Abstract
Scientific Program
Global Experts Meeting on Chronic Diseases, will be organized around the theme “Curing the Diseases for Healthy Future”
Chronic Diseases Congress 2018 is comprised of 17 tracks and 119 sessions designed to offer comprehensive sessions that address current issues in Chronic Diseases Congress 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
A chronic condition is a human health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than 3 months.
A chronic condition can be prominent from one this is acute additionally; a recurrent situation can relapse time and again, with durations of remission in between. The non-communicable diseases also are usually lasting clinical conditions but are prominent by using their non-infectious reasons. In assessment, some continual sicknesses, which include HIV/AIDS, are caused by transmissible infections.
Chronic conditions have frequently been used to explain the diverse fitness-related states of the human frame including syndromes, bodily impairments, disabilities in addition to sicknesses. Epidemiologists have determined interest in continual situations due to the fact they contribute to disease, disability, and dwindled physical and/or intellectual ability.
- Track 2-1Cancer & Nutraceuticals
- Track 2-2Dietary Supplements
- Track 2-3Nutraceuticals for Health
- Track 2-4Inflammation & Nutraceuticals
- Track 2-5Parkinson’s Disease & Nutraceuticals
- Track 2-6Functional Foods
- Track 2-7Nutraceuticals for Weight Management
- Track 3-1Lifestyle Factors
- Track 3-2Type 2 Diabetes
- Track 3-3Obesity Causes & Risk Factors
- Track 3-4Current Research & Future Challenges in Obesity
- Track 3-5Weight Loss Medications
- Track 3-6Bariatric Surgery
- Track 4-1Hepatology
- Track 4-2Hepatitis: Care & Cure
- Track 4-3Hepatic Fibrosis
- Track 4-4Hepatitis Cancer
- Track 4-5Lupoid Hepatitis
- Track 4-6Prevention of Hepatitis
- Track 5-1COPD Therapeutics
- Track 5-2Novel Therapeutics in COPD
- Track 5-3Pathogenesis of COPD
- Track 5-4Diagnostic Evaluation of COPD
- Track 5-5Management of COPD
- Track 6-1Rheumatology
- Track 6-2Autoimmunity
- Track 6-3Chronic Pain and Relief
- Track 6-4Orthopedic Trauma
- Track 6-5Physiotherapy
- Track 6-6Musculoskeletal Disorders
- Track 7-1Cardiac Arrhythmias
- Track 7-2Cardiac Regeneration
- Track 7-3Cardiovascular Genetics
- Track 7-4Cardiovascular Engineering
- Track 7-5Cardiovascular Pharmacology & Toxicology
- Track 7-6Cardiac Surgery
- Track 7-7Silent Ischemia & Ischemic Heart Disease
- Track 8-1Ischemic Stroke
- Track 8-2Memory Disorders
- Track 8-3Hemorrhagic Stroke
- Track 8-4Transient Ischemic Stroke
- Track 8-5Transient Ischemic Stroke
- Track 8-6Diagnosis & Awareness of Stroke
- Track 8-7Neuro Diagnosis & Imaging Techniques
- Track 8-8Stroke Rehabilitation & Recovery
- Track 8-9Therapeutics Approaches of Neurological Disorders
- Track 9-1Menopause Fatigue
- Track 9-2Pathophysiology
- Track 9-3Chronic Fatigue Syndrome Treatment
- Track 10-1Cancer Biology & Genetics
- Track 10-2Organ-Defined Cancers
- Track 10-3Oncology: Sub-Specialities
- Track 10-4Radiation Oncology
- Track 10-5Surgical Oncology
- Track 10-6Cancer & Stem Cell Therapy
- Track 10-7Precision Cancer Medicine & Oncology
- Track 10-8Cancer Biomarkers
- Track 10-9Cancer Epidemiology
- Track 10-10Diabetes Complications
- Track 11-1Diabetes Medications
- Track 11-2Diabetes Associated Disorders
- Track 11-3Diabetes Types & Symptoms
- Track 11-4Diabetes & Aging Process
- Track 11-5Clinical Diabetes & Diagnostic Approaches
- Track 11-6Diabetes Technology
- Track 11-7Metabolic Syndrome
- Track 12-1Cardiovascular Complications of CKD
- Track 12-2Chronic Kidney Disease Diagnosis
- Track 12-3CKD Mineral & Bone Disorder
- Track 12-4CO-Morbidities in COPD
- Track 12-5Acid Base & Electrolyte Abnormalities
- Track 12-6CKD: Fibrosis and Extracellular Matrix CKD
- Track 12-7Classification & Progression
- Track 12-8Epidemiology, Outcomes & Health Service Research in CKD
- Track 12-9Bone & Mineral Metabolism, Anemia
- Track 12-10Chronic Kidney Disease–Mesoamerican Nephropathy
- Track 12-11Chronic Kidney Disease–Diseases & Drugs
- Track 13-1HIV & Aging Pediatric HIV
- Track 13-2HIV Related Infections, Co-Infections & Cancers
- Track 13-3Immunology of HIV/AIDS, STDs & STIs
- Track 13-4HIV Prevention, Treatment & Cure
- Track 13-5HIV in Men
- Track 13-6HIV in Women
- Track 13-7HIV & Bone Damage
- Track 13-8Viral, Bacterial, Fungal & Protozoan STDs
- Track 13-9STD Symptoms
- Track 13-10HIV/AIDS, STDs & STIs
- Track 13-11Mental Disorder
- Track 13-12Complication of Eating Disorders
- Track 14-1Eating Disorder Statistics
- Track 14-2Psychopathology
- Track 14-3ICD & DSM
- Track 14-4Binge-Eating Disorder
- Track 14-5Female Eating Disorder Prevalence Rates
- Track 14-6Male Eating Disorder Statistics
- Track 15-1Psychology
- Track 15-2Schizophrenia & Chronic Mental Illness
- Track 15-3Personality Disorders
- Track 15-4Psychiatry & Psychological disorders
- Track 15-5Women’s Mental Health
- Track 15-6Anxiety & Depression Disorders
- Track 16-1Dementia-an Underlying Disease
- Track 16-2Symptoms & Diagnosis of Dementia
- Track 16-3Vascular Dementia
- Track 16-4Alzheimer’s Diagnosis & Symptoms
- Track 16-5Alzheimer’s Imaging & Clinical Trials
- Track 16-6Alzheimer’s Pathophysiology
- Track 16-7Parkinson’s Disease
Many indigenous peoples are at better threat for emerging infectious diseases in comparison to other populations.
Indigenous health refers to the physical, cultural, social and emotional wellness of Aboriginal and/or Torres Strait Islander humans (Indigenous Australians).
Many Indigenous Australians experience poorer health than different Australians, regularly demise at much more youthful ages.
Indigenous Australians are more likely than non-Indigenous Australians to have respiration sicknesses, intellectual fitness problems, cardiovascular disorder, diabetes and chronic kidney sickness. There is likewise a persisted excessive prevalence of certain illnesses - and resulting conditions - which might be now clearly unknown in the non-Indigenous populace. Notable among those are trachoma (a bacterial infection of the eye) and rheumatic heart disease.
- Track 17-1Indigenous Health in Australia
- Track 17-2Genocide of Indigenous Peoples
- Track 17-3Indigenous Genetics
- Track 17-4Indigenous Health
- Track 17-5Nutrition
- Track 17-6Indigenous Child Health